Catalog: | C-MD-0011T |
Product Type: | Test kit |
Unit: | 46 tests |
Tested parameter: | BCR-ABL p210 |
Assay time: | 2 h |
Sample type: | Bone marrow or peripheral blood |
Test type: | Quantitative |
Analysis mode: | Real-time PCR |
Application: | Lymphoma and leukemia |
This kit is used to quantitatively detect BCR-ABL p210 b2a2 and b3a2 fusion transcripts in bone marrow or peripheral blood samples of patients diagnosed with acute lymphoblastic leukemia (ALL) or chronic myeloid leukemia (CML) by real-time PCR. It can be used to monitor minimal residual disease (MRD) in patients undergoing treatment.
Copyright © 2024 Creative Biogene. All rights reserved.